By making us of the capabilities and resources available within Pharm’image, this proof of concept project consisted of performing studies from radiolabeling (antibodies, fragments, peptides) to in vivo multimodal imaging.
This project led to several publications.
The CGFL was the project leader and participated in this project in collaboration with Oncodesign, NVH Medicinal and the University of Bourgogne/Franche-Comté (ICMUB).
The BPI-FSI project started in 2009, and was continued in 2011 with a total founding of 365 k€ from BPI-France